Weight loss injection for adults with overweight or obesity
Part of Hormones & metabolism clinical trials.
This trial tests an investigational injection called MWN109 to help adults with overweight or obesity lose weight. It is a phase 3 study, meaning it is being tested in a large group of people to see how well it works and if it is safe.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 65 years old.
- You weigh at least 70 kg (about 154 lbs) if you are male, or at least 60 kg (about 132 lbs) if you are female.
- Your body mass index (BMI) is 28 or higher, or between 24 and 28 with a weight-related health condition like high blood pressure or diabetes risk.
- You have tried diet and exercise for weight loss for at least 12 weeks before joining, and your weight has been stable (less than 5% change) in the last 12 weeks.
- You agree to use effective birth control during the study and for 4 months after the last dose, if you or your partner could become pregnant.
- You do not have certain medical conditions like diabetes, pancreatitis, or a history of heart problems or depression.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new investigational injection called MWN110 in people who are overweight or have obesity. The goal is to see if the drug is safe and how it affects the body, which may help with weight management.
This study tests an investigational injection called MWN105 in people who are overweight or obese but do not have diabetes. The goal is to see if it is safe and helps with weight loss.
This study tests an experimental injection called UBT37034 to see if it is safe and how the body handles it. It is for people who are overweight but otherwise healthy. By joining, you could help find new ways to help with weight control—and you'll receive close monitoring and care.
This study tests an investigational injection called UBT251 to help people who are overweight or obese lose weight. It may also improve related health issues like high blood pressure or fatty liver. The trial lasts for a period and includes regular check-ins with the study team.
This study tests a new injection (MWN117) in healthy people and in people with obesity. It aims to see if the drug is safe and how the body handles it, which may eventually help with weight management.
This study tests a new injectable medication to help adults with obesity or overweight who don't have diabetes lose weight. It involves a reduced-calorie diet and exercise plan, and may offer an effective treatment option for weight management.
Hear when a new Overweight , Obesity trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.